Sammyboy RSS Feed
16-06-2022, 12:20 PM
An honorable member of the Coffee Shop Has Just Posted the Following:
Pfizer gives up on Paxlovid in less vulnerable COVID patients after data fail to impress
www.fiercepharma.com (http://www.fiercepharma.com)
By Angus Liu (https://www.fiercepharma.com/person/angus-liu-0)Jun 15, 2022 10:20pm
Pfizer’s Paxlovid has proven useful in COVID-19 patients at high risk of severe disease. But the antiviral drug may not help less vulnerable patients.
Pfizer has stopped enrollment into the EPIC-SR trial that’s been evaluating...
Read more (https://www.sammyboy.com/threads/pfizer-gives-up-on-paxlovid-in-less-vulnerable-covid-patients-after-data-fail-to-impress.323363/)
Click here to view the whole thread at www.sammyboy.com (https://www.sammyboy.com/threads/pfizer-gives-up-on-paxlovid-in-less-vulnerable-covid-patients-after-data-fail-to-impress.323363/).
Pfizer gives up on Paxlovid in less vulnerable COVID patients after data fail to impress
www.fiercepharma.com (http://www.fiercepharma.com)
By Angus Liu (https://www.fiercepharma.com/person/angus-liu-0)Jun 15, 2022 10:20pm
Pfizer’s Paxlovid has proven useful in COVID-19 patients at high risk of severe disease. But the antiviral drug may not help less vulnerable patients.
Pfizer has stopped enrollment into the EPIC-SR trial that’s been evaluating...
Read more (https://www.sammyboy.com/threads/pfizer-gives-up-on-paxlovid-in-less-vulnerable-covid-patients-after-data-fail-to-impress.323363/)
Click here to view the whole thread at www.sammyboy.com (https://www.sammyboy.com/threads/pfizer-gives-up-on-paxlovid-in-less-vulnerable-covid-patients-after-data-fail-to-impress.323363/).